EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert with the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model

Krassimira Todorova, Diana Zasheva, Kristiyan Kanev, Soren Hayrabedyan

Journal of Cancer Research · 2014

DOI: 10.1155/2014/840906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research, 2014. Verfasst von Krassimira Todorova und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Sciences Fund, Bulgarian Ministry of Education and Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial to mesenchymal transition is an essential step in advanced cancer development. Many master transcription factors shift their expression to drive this process, while noncoding RNAs families like miR-200 are found to restrict it. In this study we investigated how the tumor suppressor miR-204 and several transcription factors modulate main markers of mesenchymal transformation like E- and N-cadherin, SLUG, VEGF, and SOX-9 in prostate cancer cell line model (LNCaP, PC3, VCaP, and NCI-H660). We found that SLUG, E-cadherin, and N-cadherin are differentially modulated by miR-204, using miR-204 specific mimics and inhibitors and siRNA gene silencing (RUNX2, ETS-1, and cMYB). The genome perturbation associated TMPRSS2-ERG fusion coincided with shift from tumor-suppressor to tumor-promoting activity of this miRNA. The ability of miR-204 to suppress cancer cell viability and migration was lost in the fusion harboring cell lines. We found differential E-cadherin splicing corroborating to miR-204 modulatory effects. RUNX2, ETS1, and cMYB are involved in the regulation of E-cadherin, N-cadherin, and VEGFA expression. RUNX2 knockdown results in SOX9 downregulation, while ETS1 and cMYB silencing result in SOX9 upregulation in VCaP cells. Their expression was found to be also methylation dependent. Our study provides means for understanding cancer heterogeneity in regard to adapted therapeutic approaches development.

Förderung

  • National Sciences Fund, Bulgarian Ministry of Education and Sciences

Zitieren

APA

Todorova, K., Zasheva, D., Kanev, K., & Hayrabedyan, S. (2014). miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert with the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model. Journal of Cancer Research. https://doi.org/10.1155/2014/840906

Vancouver

Todorova K, Zasheva D, Kanev K, Hayrabedyan S. miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert with the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model. Journal of Cancer Research. 2014. doi:10.1155/2014/840906

BibTeX
@article{Todorova2014,
  author = {Todorova, Krassimira and Zasheva, Diana and Kanev, Kristiyan and Hayrabedyan, Soren},
  title = {miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert with the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model},
  journal = {Journal of Cancer Research},
  year = {2014},
  doi = {10.1155/2014/840906}
}
Kostenlos starten →